Fate Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FATE for the last quarter is 1.68 M USD, and it's 13.79% lower compared to the previous quarter. The net income of Q4 23 is -44.12 M USD.